Quarterly Result27 May 2026, 04:52 pm
Godavari Drugs: Audited Financial Results for March 2026
AI Summary
Godavari Drugs Ltd. has announced the approval of its audited financial results for the quarter and financial year ended March 31, 2026, during a board meeting held on May 27, 2026. The board also approved the appointment of M/s. S.K. Lahoti Associates as Internal Auditors and M/S. Bharathula & Associates as Cost Auditors for the financial year 2026-27. The 38th Annual General Meeting is scheduled for September 25, 2026, via video conferencing.
Key Highlights
- Audited financial results for quarter and year ended March 31, 2026 approved.
- M/s. S.K. Lahoti Associates appointed as Internal Auditors for FY 2026-27.
- M/S. Bharathula & Associates appointed as Cost Auditors for FY 2026-27.
- 38th Annual General Meeting scheduled for September 25, 2026, via VC.
Price Impact
More from GODAVARI